World-class pharmaceutical research undertaken at The University of Nottingham and at one of its highly successful spin-out companies has been recognised with the UKs most prestigious corporate accolade.
The Universitys School of Pharmacy, and spin-out company Molecular Profiles, a leader in the provision of innovative contract research services, have each won The Queens Award for Enterprise in the category of Innovation in 2007.
The award underlines The University of Nottinghams School of Pharmacys reputation as an international centre of excellence in research, with teaching and research teams in the UK and Malaysia delivering breakthrough results in biophysics, surface analysis, medicinal chemistry, structural biology, molecular and cellular sciences, drug delivery and tissue engineering. It is also a centre of excellence in social research in medicines and health.
The School and Molecular Profiles are singled out for enhancing significantly the development of new medicines.
The Universitys commitment to the creation of economic growth through technology transfer is reflected in the fact that two awards have been made, one to the University and one to Molecular Profiles Ltd, which is recognised for Innovation in the pharmaceutical and biomedical industries. Molecular Profiles works with most of the leading pharmaceutical companies globally, providing advanced analytical research through the combination of state-of-the-art instrumentation and scientific expertise. From its base in Nottingham the company has developed a reputation for the transfer of cutting-edge research to the world marketplace and has grown to be one of the UKs major success stories.
Sir Colin Campbell, Vice-Chancellor of The University of Nottingham, said: "This double recognition underlines the excellence of the research in our School of Pharmacy at its sites in the United Kingdom and at The University of Nottingham in Malaysia; it also reco
Contact: Lindsay Brooke
University of Nottingham